GlassScriptPhysician profile
Meaghan Stoinski
NPI 1639582851
$2,518.33
in general payments reported to CMS, 2019-2025
24 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $110 · 2021: $556 · 2022: $428 · 2023: $365 · 2024: $262 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $364.47 | 2019-2022 | |
| Acumed LLC | $363.80 | 2023-2025 | Acumed, Osteomed |
| Paragon 28, INC. | $322.66 | 2019-2021 | |
| Treace Medical Concepts, INC. | $234.71 | 2021-2023 | |
| Kerecis Limited | $189.62 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $146.27 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $133.21 | 2022 | |
| Fidia Pharma USA INC. | $92.11 | 2019-2021 | |
| Organogenesis INC. | $87.39 | 2020-2022 | |
| Smith+Nephew, INC. | $86.24 | 2019-2020 | |
| Trilliant Surgical LLC. | $81.60 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Misonix INC | $79.34 | 2019 | |
| Cardiovascular Systems INC. | $77.94 | 2019 | |
| Linvatec Corporation | $51.23 | 2021 | |
| Zimmer Biomet Holdings, INC. | $43.13 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $27.13 | 2021-2022 | |
| Zyla Life Sciences, INC. | $24.17 | 2019 | |
| Pinnacle, INC | $21.38 | 2021 | |
| Alfasigma USA, INC. | $18.49 | 2022 | |
| Melinta Therapeutics, LLC | $16.27 | 2022 | |
| Depuy Synthes Sales INC. | $16.15 | 2021 | |
| Osiris Therapeutics INC. | $15.19 | 2019 | |
| Baudax Bio INC. | $13.95 | 2022 | |
| Orthofix Medical, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meaghan Stoinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.